Invus Public Equities, Lp, Director, Ten Percent Owner at Lexicon Pharmaceuticals, holds 6.32M shares in GlycoMimetics (Ticker: GLYC), holds 11.26M shares in Scholar Rock Holding (Ticker: SRRK), holds 2.27M shares in Omega Therapeutics (Ticker: OMGA). Most recently, Invus Public Equities, Lp Sold ― shares of GlycoMimetics on Aug 09, 2024 for an estimated value of 60.63K.
What was Invus Public Equities, Lp’s latest transaction?
Invus Public Equities, Lp latest transaction was an Informative Sell of $60.63K.
What was Invus Public Equities, Lp's most profitable transaction?
Invus Public Equities, Lp’s most profitable transaction was an Informative Buy of SRRK stock on May 2, 2023. The return on the trade was 124.70%.
What is Invus Public Equities, Lp's role in Lexicon Pharmaceuticals?
Invus Public Equities, Lp's role in Lexicon Pharmaceuticals is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.